Analytical science for pharmaceutical development.
Brightlabs supports pharmaceutical organizations with method development, validation, quality control, stability studies, and specialized impurity analysis.
Pharmaceutical data must be accurate. Always.
In pharmaceutical development, the quality of your analytical data determines the certainty of every subsequent decision, from formulation to regulatory submission. A failing method, an overlooked impurity, or a stability risk discovered too late can delay a program by months. Brightlabs provides the analytical rigor to identify and manage these risks in a timely manner.
GMP
Fully accredited GMP laboratory
2015
Active in the pharmaceutical sector since our inception
Full lifecycle
From early development to commercial release
How we support pharmaceutical organizations.
01
/
Method Development & Validation
We develop and validate analytical methods from the ground up, designed for your specific compound, matrix, and regulatory context. From day one, we ensure compliance with the relevant guidelines of the International Council for Harmonisation (ICH) of Technical Requirements for Pharmaceuticals for Human Use.
02
/
Impurity Analysis
Identifying and quantifying impurities requires sensitive methods and scientific interpretation. We combine sensitive analytical techniques with scientific expertise.
03
/
Nitrosamine Analysis
As regulatory focus on nitrosamine impurities intensifies, we provide the validated methods and analytical sensitivity required for reliable compliance.
04
/
Elemental impurities
ICP-MS-based testing for elemental impurities in line with ICH Q3D—accurate, sensitive, and fully documented for regulatory submissions.
05
/
QC release testing
GMP-compliant QC testing with reliable turnaround times and full traceability, ensuring your release decisions are always based on data you can defend.
06
/
Stability Studies
We design stability programs that provide valuable and regulatory-compliant insights into shelf life and degradation at every stage of development.
Science is only as good as the people behind it.
Brightlabs was founded on a simple belief: that analytical chemistry is most valuable when driven by genuine scientific curiosity and a commitment to doing things the right way.
Insights from our laboratory
Brightlabs at CPHI Milan
Meet Brightlabs at CPHI Milan. Brightlabs will be attending CPHI Milan from 6 to 8 October 2026. We would be delighted to discuss your analytical challenges and explore how our expertise in chemical and microbiological analyses can support your product development, quality control and market launch.
A pharmaceutical analytical challenge?
Talk to one of our scientists. We will help you determine the right analytical approach for your specific situation.
